Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Capital Expenditures (2018 - 2026)

Zai Lab (ZLAB) posted Capital Expenditures of $1.2 million for Q1 2026, up 76.51% sequentially from $677000.0 in Q4 2025, and down 22.1% YoY from $1.5 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Capital Expenditures (2018 - 2026) Analysis & Trends

Zai Lab has reported Capital Expenditures for 9 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Capital Expenditures fell 22.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 24.85% YoY) and the FY2025 annual result came in at $8.1 million, up 43.2% from the prior year.
  • Capital Expenditures improved to $1.2 million in Q1 2026 per ZLAB's latest filing, from $677000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $9.7 million in Q1 2022 and troughed at $222000.0 in Q4 2023.
  • A 5-year average of $2.8 million and a median of $1.8 million in 2023 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 94.97% in 2023, then soared 1071.17% in 2024.
  • Over 5 years, Capital Expenditures stood at $4.4 million in 2022, then slumped by 94.97% to $222000.0 in 2023, then jumped by 1071.17% to $2.6 million in 2024, then tumbled by 73.96% to $677000.0 in 2025, then surged by 76.51% to $1.2 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $1.2 million, $677000.0, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn 1.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.31 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 677,000.00
Sep 30, 2025 3.01 Mn
Jun 30, 2025 2.89 Mn
Mar 31, 2025 1.53 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 741,000.00
Mar 31, 2024 974,000.00
Dec 31, 2023 222,000.00
Sep 30, 2023 1.76 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 3.51 Mn
Dec 31, 2022 4.41 Mn
Sep 30, 2022 6.68 Mn
Jun 30, 2022 3.75 Mn
Mar 31, 2022 9.74 Mn
Dec 31, 2021 6.38 Mn
Sep 30, 2021 6.27 Mn